Serotonin syndrome occurred under treatment with average dose of Venla
faxine and lithium in a 50 year-old female patient with a history of s
ensitiveness to SSRIs. Plasma levels of Venlafaxine and its metabolite
were within reference range. Parmacogenetic evalutation indicated nor
mal metabolic pathway.